Reconstruction options and outcomes for breast sarcoma patients.
Hannah M CarlNicholas A CalottaCharalampos SiotosTobias J BosDennis G FosterMichele A ManahanCarisa M CooneyJustin M SacksGedge D RossonPublished in: The breast journal (2019)
Breast sarcomas constitute a rare and heterogeneous group of tumors. Given their aggressive nature and the potential for extensive resections, rates of reconstruction have been low. We retrospectively reviewed subjects derived from our institutional registry presented between 2003 and 2015. Thirty-four patients with primary breast sarcoma were identified. The average age was 51.9 years and the average follow-up was 58 months. The most common histological type was malignant phyllodes (61.8%). Two patients suffered cancer recurrence. Twelve patients (35.3%) underwent reconstruction. Four underwent implant-based reconstruction, seven had autologous-based reconstruction, and one had combined reconstruction. Major complications were one flap loss and one implant removal. Our relatively high rates of breast reconstruction suggest a newly increased willingness to offer reconstruction to this rarer patient population.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- stem cells
- type diabetes
- squamous cell carcinoma
- breast reconstruction
- bone marrow
- patient reported outcomes
- high grade
- risk assessment
- case report
- soft tissue
- insulin resistance
- young adults
- mesenchymal stem cells
- weight loss
- liver metastases